Concepedia

Publication | Open Access

Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study

DOIFull Paper Access

29

Citations

12

References

1989

Year

Nicholas Thatcher, H Dazzi, RJ Johnson, S. Russell, AK Ghosh, Malcolm J. Moore, G. Chadwick, RDP Craig
British Journal of Cancer

References

YearCitations

Page 1